Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on May 7, 2025
Global AI in Clinical Trials Market to Show Tremendous Growth at a CAGR of ~12% by 2032 | DelveInsight
GlobeNewswire
·
May 7, 2025
New York, USA, May 07, 2025 (GLOBE NEWSWIRE) -- Global AI in Clinical Trials Market to Show Tremendous Growth at a CAGR of ~12% by 2032 | DelveInsight The demand for AI in clinical trials is experiencing strong growth, primarily fueled by the rising global …
Press release: SEQUANA MEDICAL ANNOUNCES THE ISSUANCE OF A SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM
GlobeNewswire
·
May 7, 2025
SEQUANA MEDICAL ANNOUNCES THE ISSUANCE OF A SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM Ghent, Belgium, 7 May 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in …
Recludix Pharma Presents Preclinical Data on First-in-Class BTK SH2 Domain Inhibitor Demonstrating Powerful BTK Inhibition, Exceptional Selectivity, and Encouraging Efficacy in a Model of Chronic Spontaneous Urticaria
GlobeNewswire
·
May 7, 2025
-- Bruton’s tyrosine kinase (BTK) SH2 inhibitor reduced skin inflammation in a clinically-relevant model of chronic spontaneous urticaria (CSU) -- BTK inhibition through the SH2 domain results in greater selectivity as compared to BTK tyrosine kinase …
Valneva Provides Update Following European Medicines Agency Announcement on Use of IXCHIQ® in Elderly
GlobeNewswire
·
May 7, 2025
Saint Herblain (France), May, 07 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the European Medicines Agency (EMA) has started a review of Valneva’s single-dose live attenuated chikungunya vaccine …
Valneva fait un point suite à l'annonce de l'agence européenne des médicaments sur l'utilisation d'IXCHIQ® chez les personnes âgées
GlobeNewswire
·
May 7, 2025
Saint Herblain (France), le 07 mai 2025 – Valneva SE (Nasdaq : VALN ; Euronext Paris : VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui que l’agence européenne des médicaments (EMA) a entamé une revue du vaccin vivant atténué contre le …
Minister of Education announces CPR, AED, and Opioid Overdose Response Training now mandatory part of the provincial curriculum
GlobeNewswire
·
May 7, 2025
CHARLOTTETOWN, Prince Edward Island, May 07, 2025 (GLOBE NEWSWIRE) -- The Advanced Coronary Treatment (ACT) Foundation joined the Government of Prince Edward Island (PEI), and its partners at Colonel Gray Senior High School to launch the lifesaving CPR, …
Le ministre de l'Éducation annonce que la formation en RCR, DEA et en intervention en cas de surdose d'opioïdes sera désormais obligatoire dans le programme scolaire provincial
GlobeNewswire
·
May 7, 2025
CHARLOTTETOWN, Île-du-Prince-Édouard, 07 mai 2025 (GLOBE NEWSWIRE) -- La Fondation Advanced Coronary Treatment (ACT) s’est jointe au gouvernement de l’Île-du-Prince-Édouard (Î.-P.-É.) et à ses partenaires de l’école secondaire Colonel Gray Senior High …
Arcutis Announces Publication of Positive Data from ARRECTOR Trial Evaluating ZORYVE® (roflumilast) Foam 0.3% in Individuals with Psoriasis in Journal of American Medical Association Dermatology
GlobeNewswire
·
May 7, 2025
Once-daily, investigational ZORYVE foam 0.3%, rapidly improved psoriasis of the scalp and body, including itch, when used as a monotherapy 66.4% of individuals treated with ZORYVE foam achieved Scalp-Investigator Global Assessment (S-IGA) Success at Week 8 …
Scenic Biotech Announces Nature Publication on the Discovery of Drug Target PLA2G15, a Modifier in Lysosomal Disease
GlobeNewswire
·
May 7, 2025
In collaboration with a Stanford University research team, Scenic Biotech identified and characterized PLA2G15 as a novel target in lysosomal storage diseases Amsterdam, the Netherlands, May 07, 2025 – Scenic Biotech, a pioneer in the field of modifier …
The Grove of Elmhurst Receives Enhanced Respiratory Care Accreditation
GlobeNewswire
·
May 7, 2025
Chicago, May 07, 2025 (GLOBE NEWSWIRE) -- The Physician-Patient Alliance for Health …
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
GlobeNewswire
·
May 7, 2025
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 7 May 2025 at 17.00 EEST Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion Corporation has received a disclosure …
Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.)
GlobeNewswire
·
May 7, 2025
ORION OYJ PÖRSSITIEDOTE / SUURIMMAT OSAKKEENOMISTAJAT -TIEDOTE 7.5.2025 KLO 17.00 Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.) Orion Oyj on saanut Arvopaperimarkkinalain 9. luvun 5 §:n …
TerrAscend Closes on Ohio Dispensary Acquisition
GlobeNewswire
·
May 7, 2025
Transaction marks the Company’s entry into its sixth U.S. state Acquisition is expected to be immediately accretive on an EBITDA and cashflow basis TORONTO, May 07, 2025 (GLOBE NEWSWIRE) -- TerrAscend Corp. (“TerrAscend” or the “Company”) (TSX: TSND, OTCQX …
ImmuneWalk Therapeutics Announces $7 Million Seed Financing and Upcoming Presentations of Positive Clinical Results at Upcoming Medical and Industry Conferences
GlobeNewswire
·
May 7, 2025
Completed seed financing round of $7 million from an institutional investor and ImmuneWalk’s management team Includes oral presentation of positive safety, pharmacokinetic, and pharmacodynamic data from immunology and inflammation (I…
American Kidney Fund’s Kidney Action Summit Brings AKF Ambassadors to Capitol Hill to Urge Support of Legislation to Protect Living Donors and Commitment to Protect Medicaid
GlobeNewswire
·
May 7, 2025
ROCKVILLE, Md., May 07, 2025 (GLOBE NEWSWIRE) -- Today, more than three dozen American Kidney Fund (AKF) Ambassadors will meet with lawmakers on Capitol Hill in Washington, DC, on two vital issues: removing insurance and employer roadblocks to living organ …
Theriva Biologics Announces Pricing of $7.5 Million Public Offering
GlobeNewswire
·
May 7, 2025
ROCKVILLE, Md., May 07, 2025 (GLOBE NEWSWIRE) -- Theriva Biologics (NYSE American: TOVX), (“Theriva” or the “Company”), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, …
GRI Bio Continues to Drive Enrollment in Ongoing Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis (“IPF”)
GlobeNewswire
·
May 7, 2025
Enrollment completed for the 6-week interim analysis with 24 of the 36 planned patients now enrolled Company on track to report interim biomarker data from the first 12 patients imminently Completion of patient enrollment and topline results expected Q3 …
BioRestorative to Present a BRTX-100 Clinical Update at ISCT 2025
GlobeNewswire
·
May 7, 2025
MELVILLE, N.Y., May 07, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based therapies and products, is pleased to …
PetMed Express, Inc. and Dutch Announce Partnership to Provide Accessible Telehealth Services for Pets
GlobeNewswire
·
May 7, 2025
DELRAY BEACH, Fla. and OAKLAND, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., parent company of PetMeds and PetCareRx (Nasdaq: PETS), today announced a new strategic partnership with virtual veterinary care provider Dutch. The …
Global Pet Dietary Supplements Market Surges Amid Innovation and Rising Pet Wellness Trends
GlobeNewswire
·
May 7, 2025
Delray Beach, FL, May 07, 2025 (GLOBE NEWSWIRE) -- The global pet dietary supplements market is experiencing dynamic growth, fueled by increased pet ownership, product innovation, and a heightened focus on animal wellness. As pet parents seek more …